Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China. Latest news

Different medical institutions have selected different imported and domestic brand instruments: 38 domestic and 58 imported.

Kidney disease diagnostics firm RenalytixAI announced Friday it has received a clinical laboratory permit from the New York State Department of Health allowing the company to provide its KidneyIntelX test to residents of the state. The test

HTG Molecular said on Thursday that it has signed three new European distribution agreements to promote its products and services in Nordic and Eastern Europe countries. The Tucson, Arizona-based firm signed agreements with Denmark-based Bi

An international team led by investigators at the Max Planck Institute for the Science of Human History (MPI-SHH) and the National Museums of Kenya has uncovered population patterns going back thousands of years in sub-Saharan Africa, inclu

Cue Health announced Wednesday that it has raised $100 million in Series C financing.

MilliporeSigma and 10x Genomics announced on Wednesday a collaboration on single-cell CRISPR screening workflows. The workflows will combine MilliporeSigmas CRISPR genome editing reagents with 10xs Feature Barcode assay to enable single-cel

CareDx said on Wednesday that it has priced a planned $125 million public stock offering at $32 per share. The Brisbane, California-based molecular diagnostics firm said it will offer 3,906,250 shares of its common stock through the transac

Researchers at Johns Hopkins University have developed a gene editing approach they call very fast CRISPR (vfCRISPR) that is capable of creating double-strand breaks (DSBs) in seconds, and at the submicrometer scale. During gene editing, it

Roche subsidiary Foundation Medicine announced Friday it has acquired precision oncology firm Lexent Bio to help expand its liquid biopsy platforms and advance cancer care. Financial and other details of the deal were not disclosed. Lexent

A recent genetic association study of people who are naturally thin has tied variants in the anaplastic lymphoma kinase (ALK) gene to thinness.

Genedrive said Friday that it has received the CE mark for its Genedrive 96 SARS-CoV-2 Kit and is making it available for sale in the European Union, including the UK, and other countries that accept the mark.